Health
Prostate Cancer: Over-Testing and Over-Treatment

From the Brownstone Institute
By
The excessive medical response to the Covid pandemic made one thing abundantly clear: Medical consumers really ought to do their own research into the health issues that impact them. Furthermore, it is no longer enough simply to seek out a “second opinion” or even a “third opinion” from doctors. They may well all be misinformed or biased. Furthermore, this problem appears to predate the Covid phenomenon.
A striking example of that can be found in the recent history of prostate cancer testing and treatment, which, for personal reasons, has become a subject of interest to me. In many ways, it strongly resembles the Covid calamity, where misuse of the PCR test resulted in harming the supposedly Covid-infected with destructive treatments.
Two excellent books on the subject illuminate the issues involved in prostate cancer. One is Invasion of the Prostate Snatchers by Dr. Mark Scholz and Ralph Blum. Dr. Scholtz is executive director of the Prostate Cancer Research Institute in California. The other is The Great Prostate Hoax by Richard Ablin and Ronald Piana. Richard Ablin is a pathologist who invented the PSA test but has become a vociferous critic of its widespread use as a diagnostic tool for prostate cancer.
Mandatory yearly PSA testing at many institutions opened up a gold mine for urologists, who were able to perform lucrative biopsies and prostatectomies on patients who had PSA test numbers above a certain level. However, Ablin has insisted that “routine PSA screening does far more harm to men than good.” Moreover, he maintains that the medical people involved in prostate screening and treatment represent “a self-perpetuating industry that has maimed millions of American men.”
Even during approval hearings for the PSA test, the FDA was well aware of the problems and dangers. For one thing, the test has a 78% false positive rate. An elevated PSA level can be caused by various factors besides cancer, so it is not really a test for prostate cancer. Moreover, a PSA test score can spur frightened men into getting unnecessary biopsies and harmful surgical procedures.
One person who understood the potential dangers of the test well was the chairman of the FDA’s committee, Dr. Harold Markovitz, who decided whether to approve it. He declared, “I’m afraid of this test. If it is approved, it comes out with the imprimatur of the committee…as pointed out, you can’t wash your hands of guilt. . .all this does is threaten a whole lot of men with prostate biopsy…it’s dangerous.”
In the end, the committee did not give unqualified approval to the PSA test but only approved it “with conditions.” However, subsequently, the conditions were ignored.
Nevertheless, the PSA test became celebrated as the route to salvation from prostate cancer. The Postal Service even circulated a stamp promoting yearly PSA tests in 1999. Quite a few people became wealthy and well-known at the Hybritech company, thanks to the Tandem-R PSA test, their most lucrative product.
In those days, the corrupting influence of the pharmaceutical companies on the medical device and drug approval process was already apparent. In an editorial for the Journal of the American Medical Association (quoted in Albin and Piana’s book), Dr. Marcia Angell wrote, “The pharmaceutical industry has gained unprecedented control over the evaluation of its products…there’s mounting evidence that they skew the research they sponsor to make their drugs look better and safer.” She also authored the book The Truth About the Drug Companies: How They Deceive Us and What to Do About It.
A cancer diagnosis often causes great anxiety, but in actuality, prostate cancer develops very slowly compared to other cancers and does not often pose an imminent threat to life. A chart featured in Scholz and Blum’s book compares the average length of life of people whose cancer returns after surgery. In the case of colon cancer, they live on average two more years, but prostate cancer patients live another 18.5 years.
In the overwhelming majority of cases, prostate cancer patients do not die from it but rather from something else, whether they are treated for it or not. In a 2023 article about this issue titled “To Treat or Not to Treat,” the author reports the results of a 15-year study of prostate cancer patients in the New England Journal of Medicine. Only 3% of the men in the study died of prostate cancer, and getting radiation or surgery for it did not seem to offer much statistical benefit over “active surveillance.”
Dr. Scholz confirms this, writing that “studies indicate that these treatments [radiation and surgery] reduce mortality in men with Low and Intermediate-Risk disease by only 1% to 2% and by less than 10% in men with High-Risk disease.”
Nowadays prostate surgery is a dangerous treatment choice, but it is still widely recommended by doctors, especially in Japan. Sadly, it also seems to be unnecessary. One study cited in Ablin and Piana’s book concluded that “PSA mass screening resulted in a huge increase in the number of radical prostatectomies. There is little evidence for improved survival outcomes in the recent years…”
However, a number of urologists urge their patients not to wait to get prostate surgery, threatening them with imminent death if they do not. Ralph Blum, a prostate cancer patient, was told by one urologist, “Without surgery you’ll be dead in two years.” Many will recall that similar death threats were also a common feature of Covid mRNA-injection promotion.
Weighing against prostate surgery are various risks, including death and long-term impairment, since it is a very difficult procedure, even with newer robotic technology. According to Dr. Scholz, about 1 in 600 prostate surgeries result in the death of the patient. Much higher percentages suffer from incontinence (15% to 20%) and impotence after surgery. The psychological impact of these side effects is not a minor problem for many men.
In light of the significant risks and little proven benefit of treatment, Dr. Scholz censures “the urology world’s persistent overtreatment mindset.” Clearly, excessive PSA screening led to inflicting unnecessary suffering on many men. More recently, the Covid phenomenon has been an even more dramatic case of medical overkill.
Ablin and Piana’s book makes an observation that also sheds a harsh light on the Covid medical response: “Isn’t cutting edge innovation that brings new medical technology to the market a good thing for health-care consumers? The answer is yes, but only if new technologies entering the market have proven benefit over the ones they replace.”
That last point especially applies to Japan right now, where people are being urged to receive the next-generation mRNA innovation–the self-amplifying mRNA Covid vaccine. Thankfully, a number seem to be resisting this time.
Health
Jay Bhattacharya Closes NIH’s Last Beagle Lab

From the Daily Caller News Foundation
By EMILY KOPP
The National Institutes of Health has closed the last remaining intramural beagle lab conducting painful experiments — the federal government’s largest dog lab — NIH Director Jay Bhattacharya said in a television interview Sunday.
A project at the NIH Clinical Center on “stress-induced and sepsis-induced cardiomyopathy” represented the final in-house experiments that induced pain and distress in beagles, classified under U.S. Department of Agriculture pain categories D and E. The project has now been terminated.
“We got rid of all of the beagle experiments on NIH campus,” Bhattacharya said on Fox & Friends Weekend.
Dear Readers:
As a nonprofit, we are dependent on the generosity of our readers.
Please consider making a small donation of any amount here.
Thank you!
“It’s very easy, for instance, to cure Alzheimer’s in mice. But those things don’t translate to humans,” Bhattacharya said. “So we put forward a policy to replace animals in research with technological advances, AI and other tools, that actually translate better to human health.”
NIH confirmed the news in a post on X.
Watch @NIHDirector_Jay on @FoxNews with @RCamposDuffy where he discusses a new NIH initiative to expand innovative, human-based science while reducing animal use in research, including getting rid of all the beagle experiments on the NIH campus. pic.twitter.com/qfL5oepOBX
— NIH (@NIH) May 4, 2025
The NIH has killed 2,133 beagles in septic shock experiments since 1986, according to a nine-year investigation and advocacy campaign by White Coat Waste Project. Necroposy reports from 41 beagles and other veterinary records obtained by the group through the Freedom of Information Act show that the experiments involved infecting the beagles’ lungs with pneumonia-causing bacteria to induce sepsis and sometimes bleeding them out to induce hemorrhagic shock. The dogs are then euthanized.
Beagles have been used in medical experiments because of their docile temperament. The issue garnered the attention of many on social media and in Congress in 2021 when White Coat Waste revealed evidence that NIH exported $375,800 to a Tunisian lab for experiments that induced sand flies to feed on beagles locked in cages in order to study leishmaniasis. White House Chief Medical Advisor and longtime NIH official Anthony Fauci was flooded with phone calls.
“As the watchdog that first uncovered and battled Dr. Fauci’s beagle tests (the biggest animal testing scandal in history), we’re proud that White Coat Waste has closed the NIH’s last in-house beagle laboratory—and the US government’s biggest dog lab,” said White Coat Waste Project Founder Anthony Bellotti in a statement to the Daily Caller News Foundation. “We applaud the President for cutting this wasteful NIH spending and will keep fighting until we defund all dog labs at home and abroad.”
NIH sourced beagles from contractor Envigo. Envigo reached a plea agreement in June 2024 to pay a $11 million fine for violating the Animal Welfare Act as part of a larger $35.5 million settlement, the largest-ever fine in an Animal Welfare Act case, according to the US Attorney’s Office. Inspections of a Virginia breeding facility revealed the dogs were stuffed in overcrowded kennels filled with feces and fed non-potable drinking water and rotten food.
The NIH announced on April 29 an initiative to shift away from animal experimentation toward less cruel methods more directly relevant to human health such as organoids, organs-on-a-chip, computing modeling and real-world data.
NIH made several commitments as a part of that effort, including establishing the Office of Research Innovation, Validation, and Application within Bhattacharya’s office to help scale non-animal approaches; publishing annual data on the reduction in funding for animal studies; offering more training in non-animal approaches and integrating that expertise into the study sections that make determinations about NIH extramural grants.
As recently as April 15, a longtime NIH official had defended the beagle experiments, saying that “current canine models of sepsis offer several advantages in research, including similar cardiovascular anatomy and the ability to induce sepsis through mechanisms that mimic what occurs in humans,” according to an email from NIH to congressional aides shared with the DCNF.
Health
RFK Jr. orders placebo safety trials for all new vaccines in major policy decision

From LifeSiteNews
Placebo trials are critical for determining a new drug’s safety and identifying side effects, but vaccines have been exempt from the requirement for such safety testing until now.
All new vaccines will be required to undergo placebo-controlled safety trials by the order of Robert F. Kennedy Jr., head of the Department of Health and Human Services (HHS), in a break with longstanding establishment policy and triggering protests from mainstream media outlets.
HHS spokesman Andrew Nixon said that, according to the new policy, such safety trials for all “new vaccines” will be required for licensure, a “radical departure from past practices.”
Placebo trials allow researchers to identify adverse side effects from a drug, clarifying that symptoms are not due to other factors such as the disease the drug seeks to protect against. For this reason, placebo trials are “critical for determining the safety profile of the new drug,” as BioPharma Services has noted.
“Except for the COVID vaccine, none of the vaccines on the CDC’s childhood recommended schedule was tested against an inert placebo, meaning we know very little about the actual risk profiles of these products,” HHS said in a statement.
“HHS is now building surveillance systems that will accurately measure vaccine risks as well as benefits — because real science demands both transparency and accountability,” an HHS spokesperson told The Washington Post.
For years, Kennedy has criticized the fact that vaccines have been exempted from a placebo trial requirement in place for other medicines.
“A lot of the injuries that come from medication are autoimmune injuries and allergic injuries and neurodevelopmental injuries that have long diagnostic horizons or long incubation periods, so you can do the study and you will not see the injury for five years,” Kennedy said in a 2021 interview.
Last year, during a NewsNation Town Hall he highlighted the fact that not one of the 72 vaccine doses now mandated for U.S. children “has ever been subject to a pre-licensing, placebo-controlled trial.”
At the time, the host insisted that this was “not true.” Now that the mainstream media and medical establishment cannot dispute that this has been the case, outlets such as NPR and the BBC are criticizing placebo safety testing trials by claiming that this will allegedly limit access to vaccines and undermine confidence in them – as if access to vaccines takes precedence over whether they have been shown to be safe.
The Washington Post quoted Dorit Reiss, a professor at the University of California College of the Law, who accused the HHS of “Claiming vaccines have risks the data doesn’t show” and of “trying to overstate vaccine risks,” seemingly unaware of the absurdity of her criticism. If there is a lack of data for vaccine risks, it could be because there haven’t been placebo trials to produce such data.
Kennedy recently told Daily Wire host Michael Knowles that “everything is going to change” regarding the development of vaccines, for which much of the public has concern.
He pledged to “fix” the Centers for Disease Control’s current flawed VAERS (Vaccine Adverse Event Reporting System) online mechanism, which Kennedy noted vastly underreports vaccine adverse events.
Pointing out that vaccines are “the only product that’s exempt” from pre-licensing safety testing, Kennedy noted that the protocol has instead been to document injuries “afterward.”
However, “they have a system that doesn’t capture them. In fact, CDC’s own study of its own system said it captures fewer than 1% of vaccine injuries,” Kennedy said. “It’s worthless, and everybody agrees it’s worthless.”
“Why have we gone for 39 years and nobody’s fixed it?” he wondered, promising, “We’re gonna fix it.”
-
Business2 days ago
Carney poised to dethrone Trudeau as biggest spender in Canadian history
-
2025 Federal Election2 days ago
Mark Carney vows to ‘deepen’ Canada’s ties with the world, usher in ‘new economy’
-
Crime2 days ago
Mexican Cartels smuggling crude oil in Texas, Southwest border
-
Economy2 days ago
US strategy to broker peace in Congo and Rwanda – backed by rare earth minerals deal
-
Alberta2 days ago
Pierre Poilievre will run to represent Camrose, Stettler, Hanna, and Drumheller in Central Alberta by-election
-
Alberta13 hours ago
Bonnyville RCMP targeted by suspect driving a trackhoe
-
Business2 days ago
Federal government’s accounting change reduces transparency and accountability
-
International2 days ago
Pentagon Salivates Over ‘Expensive’ Weapons While China Races Into Future With Iron Grip Over Cheap Drone Tech